•
Mar 30, 2024

Thermo Fisher Q1 2024 Earnings Report

Thermo Fisher Scientific reported strong financial results driven by its proven growth strategy and the impact of its PPI Business System.

Key Takeaways

Thermo Fisher Scientific reported a revenue decline of 3% to $10.34 billion. GAAP diluted EPS increased 4% to $3.46, and adjusted EPS increased 2% to $5.11. The company is raising its full year revenue and adjusted EPS guidance to reflect stronger operational performance.

First quarter revenue was $10.34 billion.

First quarter GAAP diluted earnings per share (EPS) increased 4% to $3.46.

First quarter adjusted EPS increased 2% to $5.11.

Active quarter of capital deployment, repurchasing $3.0 billion of stock and increasing our dividend by 11 percent.

Total Revenue
$10.3B
Previous year: $10.7B
-3.4%
EPS
$5.11
Previous year: $5.03
+1.6%
Organic Revenue Growth
-4%
Previous year: -8%
-50.0%
Gross Profit
$4.22B
Previous year: $4.27B
-1.3%
Cash and Equivalents
$5.5B
Previous year: $3.48B
+57.9%
Free Cash Flow
$908M
Previous year: $277M
+227.8%
Total Assets
$97.1B
Previous year: $94.7B
+2.6%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

Thermo Fisher is raising its full year revenue and adjusted EPS guidance to reflect stronger operational performance. The company is raising its revenue guidance to a new range of $42.3 to $43.3 billion versus its previous guidance of $42.1 to $43.3 billion. The company is raising its adjusted EPS guidance to a new range of $21.14 to $22.02 versus its previous guidance of $20.95 to $22.00.

Revenue & Expenses

Visualization of income flow from segment revenue to net income